Image

Flemish Inguinal and Femoral Hernia Prospective Registry

Flemish Inguinal and Femoral Hernia Prospective Registry

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Prospective registry. The purpose of this clinical trial will be to measure surgical outcome parameters (e.g. recurrence, chronic pain and other quality indicators) after inguinal hernia repair using Patient Reported Outcome Measures (PROMs) in the short- and long-term.

Description

The primary objective is to investigate moderate to severe chronic pain 1 year after inguinal or femoral hernia repair, defined as numeric rating scale (NRS) ≥ 4, during daily activities.

The secondary objectives are:

  • Surgical Site Occurrence (SSO) after 30 days
  • Scope and incidence of pre- and postoperative pain (NRS 0 to 10)
  • The difference between pre- and postoperative NRS scores (relative NRS score)
  • Presence of pain and impact of pain on daily life activities
  • Satisfaction and quality of life
  • Sexual function
  • Anxiety and depression
  • Catastrophizing
  • Recurrence
  • Development of a predictive model for chronic pain.

Eligibility

Inclusion criteria

  • Consecutively all patients with a groin hernia (inguinal and/or femoral hernia) operated starting 01.01.2018.
  • Male and female
  • 18 years or older
  • Operated of supervised by a participating surgeon (participating in this study is not necessarily by a whole surgical department of a hospital, but by specific surgeons)
  • Elective and emergency surgery
  • Primary and recurrent hernia
  • Metachronous and synchronous hernia
  • Signed informed consent form

Exclusion criteria

  • Younger than 18 years
  • Not operated or supervised by participating surgeon
  • Pregnant at inclusion in the registry
  • No signed informed consent form

Study details
    Inguinal Hernia

NCT04623580

Universitaire Ziekenhuizen KU Leuven

25 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.